Interpace Biosciences Inc Preço/Valor Contábil
Qual é o Preço/Valor Contábil de Interpace Biosciences Inc?
O Preço/Valor Contábil de Interpace Biosciences Inc é -0.07
Qual é a definição de Preço/Valor Contábil?
A razão entre cotação e valor contabilístico representa a razão entre o valor das ações de uma empresa e o valor contábil por ação.
The price to book ratio, or P/B ratio, is a financial ratio used to compare a company's current market price to its book value. It is also sometimes known as a market to book ratio or price to equity ratio. The calculation of a price to book ratio can be performed in two ways. It can be calculated as the company's market capitalization divided by the company's total book value from its balance sheet. It can also be calculated using per-share values and dividing a company's current share price by the book value per share (i.e. its book value divided by the number of outstanding shares).
The P/B ratio varies between industries. The industries that require more infrastructure capital (for each dollar of profit) will usually trade at P/B ratios much lower than, for example, consulting firms. P/B ratios are commonly used to compare banks, because most assets and liabilities of banks are constantly valued at market values. A higher P/B ratio implies that investors expect management to create more value from a given set of assets, all else equal (and/or that the market value of the firm's assets is significantly higher than their accounting value).
P/B ratios do not, however, directly provide any information on the ability of the firm to generate profits or cash for shareholders. This ratio also gives some idea of whether an investor is paying too much for what would be left if the company went bankrupt immediately. For companies in distress, the book value is usually calculated without the intangible assets that would have no resale value. In such cases, P/B should also be calculated on a "diluted" basis, because stock options may well vest on sale of the company or change of control or firing of management.
Preço/Valor Contábil de empresas na Setor Health Care em NASDAQ em comparação com Interpace Biosciences Inc
O que Interpace Biosciences Inc faz?
advancing patient care through molecular diagnostic testing. interpace diagnostics develops molecular diagnostic tests. our molecular diagnostic tests provide unparalleled accuracy and clarity to improve outcomes in patients facing a cancer diagnosis. you can be assured that all of the molecular tests we offer are driven by rigorous, validated science. we power the future of molecular diagnostics, delivering cutting-edge and much-needed mutational analysis that helps risk-stratify for thyroid, pancreatic, and other cancers to better inform treatment decisions. the unique molecular diagnostic tests we offer enable healthcare providers to avoid unnecessary surgeries and better assess the risk of cancer progression in their patients.
Empresas com preço/valor contábil semelhantes a Interpace Biosciences Inc
- China Rundong Auto tem Preço/Valor Contábil de -0.07
- Uttam Value Steels tem Preço/Valor Contábil de -0.07
- Ferrellgas Partners tem Preço/Valor Contábil de -0.07
- Wheeler Real Estate Investment Trust Inc tem Preço/Valor Contábil de -0.07
- ION Geophysical Corp tem Preço/Valor Contábil de -0.07
- Invigor tem Preço/Valor Contábil de -0.07
- Interpace Biosciences Inc tem Preço/Valor Contábil de -0.07
- Federal National Mortgage Association tem Preço/Valor Contábil de -0.07
- Premier tem Preço/Valor Contábil de -0.07
- Bombay Rayon Fashions tem Preço/Valor Contábil de -0.07
- Supreme Infrastructure India tem Preço/Valor Contábil de -0.07
- AI Technology tem Preço/Valor Contábil de -0.07
- Sparta Commercial Services tem Preço/Valor Contábil de -0.07